Close
Digital Health & Ai Innovation summit 2026
APE 2026

Research Insight

Syapse and FDA Expand Existing Research Collaboration to Rapidly Generate Real-World Evidence Related to COVID-19 and Cancer

Syapse®, a real-world data company accelerating the delivery of precision medicine through the Syapse Learning Health NetworkTM, and the U.S. FDA Oncology Center of Excellence...

Majority of Americans taking Blood Thinners indicate the fear of major bleeding.

A majority (55 percent) of Americans aged 18 and older currently prescribed anticoagulant medications (blood thinners) report that they very much or somewhat fear experiencing...

Digital platform to reduce the risk of infections during surgery

One in ten people in hospital care develops a healthcare-related infection. Together with Getinge, Semcon is developing a new digital platform to make it easier...

Improving the lives of patients suffering from chronic pain

For patients suffering from chronic pain, their lives can be miserable if the pain relief on which they rely is inefficient. It is essential, therefore,...

University of Glasgow leads COVID-19 research response in Scotland

The University of Glasgow is at the heart of COVID-19 research response in Scotland and the UK. Covid-19 is a new disease in humans, caused...

St. Elizabeth Healthcare Partners with CTI and Pulmotect Becoming First Hospital Site for Phase-2 Clinical Trial Targeting COVID-19

St. Elizabeth Healthcare has been selected as the first site of the FDA-approved Phase-2 COVID-19 clinical trial studying the drug PUL-042 of Pulmotect, Inc., in...

Is CBD Ready To Start Getting Prescribed By Doctors?

It seems that CBD is on the verge of becoming adopted by the masses and is more mainstream by the week. It is being used...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »